Literature DB >> 18004121

The effect of long-acting risperidone on working memory in schizophrenia: a functional magnetic resonance imaging study.

Simon A Surguladze1, Elvina M Chu, Anthony Evans, Anantha P P Anilkumar, Maxine X Patel, Clive Timehin, Anthony S David.   

Abstract

Cognitive abnormalities represent an important therapeutic target in the treatment of schizophrenia. Working memory deficits are among the core abnormalities and affect social functioning. We used functional magnetic resonance imaging to examine cortical systems supporting working memory in patients with schizophrenia treated with risperidone long-acting injections (RLAIs) versus those on conventional depot medication (CONV). Sixteen patients on RLAI, 16 patients on CONV matched for clinical symptoms and other illness variables, and 8 HCs performed an n-back task (1-, 2-, 3-back) in the scanner. The level of performance decreased with increasing memory load, which was particularly evident in the CONV group. Patients on RLAI and controls demonstrated task-dependent decreases in activation in medial PFC, whereas the CONV group overactivated that region. The CONV group also showed underactivation of VLPFC compared with controls under conditions of increasing memory load, with the RLAI group showing an activation pattern not significantly different from either group. We conclude that RLAI may contribute to normalization of brain activation in regions involved in working memory functioning in people with chronic schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18004121     DOI: 10.1097/jcp.0b013e31815a256c

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  8 in total

Review 1.  Potential microbial origins of schizophrenia and their treatments.

Authors:  S Hossein Fatemi
Journal:  Drugs Today (Barc)       Date:  2009-04       Impact factor: 2.245

2.  Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy.

Authors:  Anne Schmechtig; Jane Lees; Lois Grayson; Kevin J Craig; Rukiya Dadhiwala; Gerard R Dawson; J F William Deakin; Colin T Dourish; Ivan Koychev; Katrina McMullen; Ellen M Migo; Charlotte Perry; Lawrence Wilkinson; Robin Morris; Steve C R Williams; Ulrich Ettinger
Journal:  Psychopharmacology (Berl)       Date:  2013-02-22       Impact factor: 4.530

3.  An event-related FMRI study of phonological verbal working memory in schizophrenia.

Authors:  Jejoong Kim; Natasha L Matthews; Sohee Park
Journal:  PLoS One       Date:  2010-08-11       Impact factor: 3.240

4.  Emerging treatments in the management of bipolar disorder - focus on risperidone long acting injection.

Authors:  Wissam El-Hage; Simon A Surguladze
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

Review 5.  The neurodevelopmental hypothesis of schizophrenia, revisited.

Authors:  S Hossein Fatemi; Timothy D Folsom
Journal:  Schizophr Bull       Date:  2009-02-17       Impact factor: 9.306

6.  Functional magnetic resonance imaging of a parametric working memory task in schizophrenia: relationship with performance and effects of antipsychotic treatment.

Authors:  Ulrich Ettinger; Steven C R Williams; Dominic Fannon; Preethi Premkumar; Elizabeth Kuipers; Hans-Jürgen Möller; Veena Kumari
Journal:  Psychopharmacology (Berl)       Date:  2011-02-18       Impact factor: 4.530

Review 7.  Functional magnetic resonance imaging in schizophrenia.

Authors:  Raquel E Gur; Ruben C Gur
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

Review 8.  Pharmacological Interventions for the MATRICS Cognitive Domains in Schizophrenia: What's the Evidence?

Authors:  Wilhelmina A M Vingerhoets; Oswald J N Bloemen; Geor Bakker; Therese A M J van Amelsvoort
Journal:  Front Psychiatry       Date:  2013-12-04       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.